CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 8-K Event Bylaws or fiscal year change
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market sale CFO and CBO sold 2,127 shares at $7.24 ($15,403)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 7,500 shares at an average $7.81 ($58,580)
- 4 Open-market sale CFO and CBO sold 12,492 shares at an average $8.88 ($110,871)
- 4 Grant or award Chief Operating Officer acquired 32,500 shares (grant or award)
- 4 Grant or award President and Chief Executive acquired 37,500 shares (grant or award)
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Results of operations
Page 10 of 25 · 496 filings